Skip to content

CDR

Merck Adherence Estimator demonstrates worth

The Adherence Estimator, a patient segmentation tool developed by researchers at Merck & Co. to help pharmacists and other health care professionals identify and assist individuals prone to medication nonadherence, has proved its worth in a variety of practice settings since its debut last year.

Lannett gets OK for morphine sulfate solution

Lannett Co. has received Food and Drug Administration approval for its 505(b)(2) New Drug Application (NDA) for morphine sulfate oral solution. Lannett said Friday that it expects to begin shipping the pain relief drug soon.

Newell Rubbermaid names Polk as CEO

Former Unilever executive Michael Polk has been appointed president and chief executive officer at Newell Rubbermaid. The general merchandise maker said late Thursday that Polk, 50, is slated to take the helm as CEO on July 18.

Mylan set to ship Entocort generic

In the wake of a court decision, Mylan Inc. plans to roll out enteric-coated budesonide capsules, a medication for Crohn’s disease. The company said late Thursday that the U.S. District Court for the District of Delaware ruled that its Mylan Pharmaceuticals Inc.

Dr. Reddy’s launches generic Levaquin

Dr. Reddy’s Laboratories this week began shipping levofloxacin tablets in the U.S. market after receiving Food and Drug Administration approval for the antibiotic medication. The company said Wednesday that it’s offering levofloxacin tablets, a bioequivalent generic version of Daiichi Sankyo Co.

PNI, CVS renew online photo services pact

PNI Digital Media has extended its online photo services contract with CVS/pharmacy. The retailer digital media provider said Wednesday that the deal adds three years to its Internet services agreement with CVS to provide and operate the drug store chain’s online photo service, cvsphoto.

CalPERS awards Rx contract to CVS Caremark

The California Public Employees’ Retirement System (CalPERS), one of the nation’s largest pension funds, has chosen CVS Caremark Corp. to administer prescription drug benefits for members of its preferred provider organization (PPO) health plans.

Net loss decreases at Rite Aid in 1Q

Rite Aid Corp. beat Wall Street’s projection for its fiscal 2012 first quarter by turning in a smaller net loss on flat sales. The drug store chain said Thursday that for the 13-week first quarter ended May 28 it recorded a net loss of $63.1 million, or 7 cents per diluted